1 / 20

Impact of Higher Hemoglobin on Mortality in Hemodialysis Patients

Explore the relationship between hemoglobin levels and mortality risk in hemodialysis patients. Detailed analysis of DOPPS data and guidelines for interpreting findings.

sereno
Télécharger la présentation

Impact of Higher Hemoglobin on Mortality in Hemodialysis Patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. When Using DOPPS Slides

  2. DOPPS Slide Use Guidelines

  3. Naturally Occurring Higher Hemoglobin Concentration Does Not Increase Mortality among Hemodialysis Patients

  4. Introduction

  5. DOPPS Background (1)

  6. DOPPS Background (2)

  7. Methods (1)

  8. Methods (2)

  9. Methods (3)

  10. Table 1. Patient Characteristics by Endogenous EPO Status and Region

  11. Table 1. Patient Characteristics by Endogenous EPO Status and Region

  12. Table 1. Patient Characteristics by Endogenous EPO Status and Region

  13. Table 1. Patient Characteristics by Endogenous EPO Status and Region

  14. Table 1. Patient Characteristics by Endogenous EPO Status and Region

  15. Figure 1. Prevalence of Endogenous EPO Patients, by Country, Among Initial Sampling of Each Study Phase

  16. Table 2. Associations between Patient Characteristics and Likelihood of Endogenous EPO Status

  17. Table 2. Associations between Patient Characteristics and Likelihood of Endogenous EPO Status

  18. Figure 2. Relative Risk of Mortality for Endogenous EPO Patients Compared with Other Patients

  19. Results

  20. Conclusions

More Related